|
|
|
|
Health Care & Health-IT Under Obama
Digital HealthCare & Productivity | WASHINGTON—The election of Barack Obama as president and the solidification of the Democratic majority in Congress clearly will have an effect on the national health care agenda for 2009, but some of the reasons might not be so obvious.
|
|
Health IT Certification Moves Forward
Digital HealthCare & Productivity | WASHINGTON—The American Medical Informatics Association (AMIA) is turning its attention to medical specialty boards in its bid for recognition of clinical informatics as a distinct medical subspecialty, following the approval of detailed plans for physician informatician training and competency.
|
|
Fed Report Calls on NIH to Blaze Personalized Medicine Trail
Digital HealthCare & Productivity | It’s a busy time on the personalized medicine front. The recently-released federal government report, Priorities for Personalized Medicine, is gradually attracting attention. The state of Wisconsin last week jumped into the race to become a center for personalized medicine. And a group of technology providers has joined Scripps Translational Science Institute (STSI) to study to what extent people make behavioral changes when they are provided with genetic screening and information about their various risk factors.
|
|
Certifying PHRs
Digital HealthCare & Productivity | The first set of certification criteria for personal health records (PHRs) products will focus more on privacy, security, and interoperability with other health-IT and less on specific functionality in an effort to foster innovation in a relatively new market segment, according to the Certification Commission for Healthcare Information Technology (CCHIT).
|
|
CCHIT Certifies EHRs and HIEs
Digital HealthCare & Productivity | On Tuesday, CCHIT said that eight ambulatory electronic health records (EHR) products earned full certification under the new 2008 criteria for interoperability. Tomorrow, CCHIT will open the first-ever application period for certification of health information exchanges (HIE).
|
|
Warfarin Test: Who Should Pay for Personalized Medicine?
Digital HealthCare & Productivity | Payers, physicians, and the pharmaceutical industry are closely watching CMS deliberations over whether or not to pay for a genetic-based test that provides guidance on Warfarin dosing. The FDA, which approved the test, says it’s an important tool, but the CMS isn’t so sure and opened a National Coverage Analysis (NCA) on the subject in August.
|
|
Privacy Certification Program Aims to Ensure Patients’ Trust
Digital HealthCare & Productivity | A former senior advisor in the Department of Health and Human Services (HHS) is heading up the first large-scale effort to certify health-IT products for adherence to privacy standards.
|
|
Lively Debate at HIPAA Summit at Harvard
Digital HealthCare & Productivity | Are patient privacy rules effective? The answer is not a simple yes or no. “It’s working, but it’s got a ways to go,” suggests William Braithwaite, chief medical officer of San Diego-based security and identity management company Anakam.
|
|
Karen Trudel of CMS Talks about HIPAA Audits and NPI Issues
Digital HealthCare & Productivity | In the wake of one of the largest fines levied by HHS for a HIPAA (Health Insurance Portability and Accountability Act) violation, HIPAA official Karen Trudel says to expect further audits and enforcement proceedings as federal officials begin to extend compliance reviews.
|
|
Security Features Not Limited to Paper
Digital HealthCare & Productivity | Electronic prescribers who want to print prescriptions for Medicaid patients no longer will have to spend up to 10 times the cost of plain paper to comply with new tamper-resistance regulations, the result of intense negotiations between government officials, medical societies, the pharmacy industry, paper manufacturers, and two health-IT advocacy groups.
|
Turning Genomics Data into Practical Insight With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can: - Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines.
- Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image).
Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands.
New Complimentary Market Survey… Collaborations and Communications Within Drug Discovery Research This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns. An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide
Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:
- Current practices in clinical trial logistics
- Comparing advances in clinical supply practices to other aspects of clinical trials
- Where current practices fall short of meeting the challenges
- Trends and evolving improvements that may change the way logistics are conducted
Listen Now
More Podcasts
Scientific Software Engineer
Boston MA
$70,000 to $95,000
Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET.
Apply at http://jobs.tessella.com
Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes. As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers. This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions. It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply
Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules. It is therefore suitable for use in a variety of markets including scientific research and clinical applications. As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team. The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market. This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company. Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial leadership, who wish to apply a fresh approach to existing markets. Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries. We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products. Click to Apply
|
|
|